Commission Directive 2008/44/EC of 4 April 2008 amending Council Directive 91/414/EEC to include benthiavalicarb, boscalid, carvone, fluoxastrobin, Paecilomyces lilacinus and prothioconazole as active substances (Text with EEA relevance)
Date: 2008-04-04
Institutions: European Commission
Subjects: chemical product, exchange of information, market approval, marketing standard, pesticide, pharmaceutical product, plant health legislation, plant health product

5.4.2008

EN

Official Journal of the European Union

L 94/13

COMMISSION DIRECTIVE 2008/44/EC

of 4 April 2008

amending Council Directive 91/414/EEC to include benthiavalicarb, boscalid, carvone, fluoxastrobin,
Paecilomyces lilacinus and prothioconazole as active substances

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

considered as satisfying, in principle, the data and infor-
mation requirements of Annexes II and III to Directive
91/414/EEC.

Having regard to the Treaty
Community,

establishing the European

Having regard to Council Directive 91/414/EEC of 15 July 1991
concerning the placing of plant protection products on the
market (1), and in particular Article 6(1) thereof,

Whereas:

(1)

(2)

(3)

In accordance with Article 6(2) of Directive 91/414/EEC
Belgium received on 19 April 2002 an application from
Kumiai Chemicals Industry Co. Ltd for the inclusion of
to
the active substance benthiavalicarb in Annex I
Directive
Decision
2003/35/EC (2)
dossier was
‘complete’
in the sense that it could be considered as
and information
satisfying,
in principle,
to Directive
requirements of Annexes
91/414/EEC.

Commission
that

91/414/EEC.

confirmed

the data

and III

the

II

in Annex

the inclusion of
I

In accordance with Article 6(2) of Directive 91/414/EEC
Germany received on 26 April 2001 an application from
the active substance
BASF AG for
boscalid
91/414/EEC.
Commission Decision 2002/268/EC (3) confirmed that
the dossier was ‘complete’ in the sense that it could be
considered as satisfying, in principle, the data and infor-
mation requirements of Annexes II and III to Directive
91/414/EEC.

to Directive

In accordance with Article 6(2) of Directive 91/414/EEC
the Netherlands received on 26 March 1997 an appli-
cation from Luxan B.V. for the inclusion of the active
substance carvone in Annex I to Directive 91/414/EEC.
Commission Decision 1999/610/EC (4) confirmed that
the dossier was ‘complete’ in the sense that it could be

(1) OJ L 230, 19.8.1991, p. 1. Directive as

last amended by

Commission Directive 2008/41/EC (OJ L 89, 1.4.2008, p. 12).

(2) OJ L 11, 16.1.2003, p. 52.
(3) OJ L 92, 9.4.2002, p. 34.
(4) OJ L 242, 14.9.1999, p. 29.

(4)

(5)

(6)

(7)

fluoxastrobin in Annex

In accordance with Article 6(2) of Directive 91/414/EEC
United Kingdom received on 25 March 2002 an appli-
cation from Bayer AG for the inclusion of the active
to Directive
substance
91/414/EEC. Decision 2003/35/EC confirmed that the
dossier was ‘complete’
it could be
considered as satisfying, in principle, the data and infor-
mation requirements of Annexes II and III to Directive
91/414/EEC.

in the sense that

I

In accordance with Article 6(2) of Directive 91/414/EEC
Belgium received on 15 September 2002 an application
from Prophyta for the inclusion of the active substance
lilacinus strain 251 (hereafter Paecilomyces
Paecilomyces
lilacinus)
91/414/EEC.
to Directive
Commission Decision 2003/305/EC (5) confirmed that
the dossier was ‘complete’ in the sense that it could be
considered as satisfying, in principle, the data and infor-
mation requirements of Annexes II and III to Directive
91/414/EEC.

in Annex

I

In accordance with Article 6(2) of Directive 91/414/EEC
United Kingdom received on 25 March 2002 an appli-
cation from Bayer CropScience for the inclusion of the
active substance prothioconazole in Annex I to Directive
91/414/EEC. Decision 2003/35/EC confirmed that the
dossier was ‘complete’
it could be
considered as satisfying, in principle, the data and infor-
mation requirements of Annexes II and III to Directive
91/414/EEC.

in the sense that

For those active substances, the effects on human health
and the environment have been assessed, in accordance
with the provisions of Article 6(2) and (4) of Directive
91/414/EEC, for the uses proposed by the applicants. The
designated rapporteur Member States submitted draft
assessment report on 13 April 2004 (benthiavalicarb),
22 November 2002 (boscalid), 16 October 2000
(fluoxastrobin),
(carvone),
lilacinus)
3
and
18 October 2004 (prothioconazole).

2003
(Paecilomyces

September
2004

2
November

(5) OJ L 112, 6.5.2003, p. 10.

L 94/14

EN

Official Journal of the European Union

5.4.2008

reviewed by the
reports were peer
The assessment
Member States and the EFSA within its Working Group
Evaluation and presented to the Commission in the
format of the EFSA Scientific Reports on 15 June 2007
for fluoxastrobin (1) and Paecilomyces lilacinus (2) and on
12 July for benthiavalicarb (3) and prothioconazole (4).
These reports and the draft assessment
for
boscalid and carvone were reviewed by the Member
States
Standing
Committee on the Food Chain and Animal Health and
the review was finalised on 22 January 2008 in the
format of the Commission review reports for benthiava-
Paecilomyces
licarb, boscalid,
lilacinus and prothioconazole.

and the Commission within the

fluoxastrobin,

carvone,

reports

lilacinus or prothioconazole

substance in Annex I, Member States should be allowed a
period of six months after inclusion to review existing
provisional authorisations of plant protection products
fluoxas-
containing benthiavalicarb, boscalid, carvone,
trobin, Paecilomyces
to
the requirements laid down by Directive
ensure that
in its Article 13 and the
91/414/EEC,
in particular
relevant conditions set out
in Annex I, are satisfied.
Member States should transform existing provisional
authorisations into full authorisations, amend them or
withdraw them in accordance with the provisions of
Directive 91/414/EEC. By derogation from the above
deadline, a longer period should be provided for the
submission and assessment of the complete Annex III
for each
dossier of each plant protection product
intended use in accordance with the uniform principles
laid down in Directive 91/414/EEC.

(8)

(9)

the

products

protection

containing

It has appeared from the various examinations made that
active
plant
substances concerned may be expected to satisfy,
in
general, the requirements laid down in Article 5(1) (a)
and (b) and Article 5(3) of Directive 91/414/EEC,
in
particular with regard to the uses which were examined
and detailed in the Commission review report.
is
benthiavalicarb,
therefore
lilacinus
boscalid,
and prothioconazole in Annex I to that Directive,
in
order to ensure that in all Member States the authorisa-
tions of plant protection products containing these active
substances may be granted in accordance with the
provisions of that Directive.

include
fluoxastrobin, Paecilomyces

appropriate

carvone,

to

It

certain

specific

information

(10) Without prejudice to the above conclusion, for fluoxas-
trobin and prothioconazole it is appropriate to obtain
points.
further
on
Article 6(1) of Directive 91/414/EEC provides
that
inclusion of a substance in Annex I may be subject to
conditions. Therefore,
it is appropriate to require that
fluoxastrobin should be subjected to further testing for
confirmation of the risk assessment for surface water and
for non-rat metabolites and that prothioconazole should
be subjected to further testing for confirmation of the
risk assessment as regards the triazole metabolite deriva-
tives and the risk to granivorous birds and mammals and
that such studies should be presented by the notifiers.

(12)

(13)

is

It
therefore
91/414/EEC accordingly.

appropriate

to

amend Directive

The measures provided for
accordance with
Committee on the Food Chain and Animal Health,

in this Directive are in
Standing
the

opinion

the

of

HAS ADOPTED THIS DIRECTIVE:

Article 1

Annex I to Directive 91/414/EEC is amended as set out in the
Annex to this Directive.

Article 2

the latest

1. Member States shall adopt and publish by 31 January
2009 at
the laws, regulations and administrative
provisions necessary to comply with this Directive. They shall
forthwith communicate to the Commission the text of those
provisions and a correlation table between those provisions and
this Directive.

(11) Without prejudice to the obligations defined by Directive
including an active

91/414/EEC as a consequence of

They shall apply those provisions from 1 February 2009.

(1) EFSA Scientific Report (2007) 102, 1-84, Conclusion regarding the
peer review of the pesticide risk assessment of the active substance
fluoxastrobin (finalised: 13 June 2007).

(2) EFSA Scientific Report (2007) 103, 1-35, Conclusion regarding the
peer review of the pesticide risk assessment of the active substance
Paecilomyces lilacinus strain 251 (finalised: 13 June 2007).

(3) EFSA Scientific Report (2007) 107, 1-81, Conclusion regarding the
peer review of the pesticide risk assessment of the active substance
benthiavalicarb (finalised: 12 July 2007).

(4) EFSA Scientific Report (2007) 106, 1-98, Conclusion regarding the
peer review of the pesticide risk assessment of the active substance
prothioconazole (finalised: 12 July 2007).

When Member States adopt those provisions, they shall contain
a reference to this Directive or shall be accompanied by such a
reference on the occasion of their official publication. Member
States shall determine how such reference is to be made.

2. Member States shall communicate to the Commission the
text of the main provisions of national law which they adopt in
the field covered by this Directive.

5.4.2008

EN

Official Journal of the European Union

L 94/15

Article 3

Following that determination Member States shall:

shall

States

1. Member
in accordance with Directive
91/414/EEC, where necessary, amend or withdraw existing
authorisations for plant protection products containing benthia-
valicarb, boscalid, carvone, fluoxastrobin, Paecilomyces lilacinus or
prothioconazole as active substance by 31 January 2009. By
that date, they shall in particular verify that the conditions in
Annex I to that Directive relating to benthiavalicarb, boscalid,
carvone, fluoxastrobin, Paecilomyces lilacinus or prothioconazole,
respectively, are met, with the exception of those identified in
part B of the entry concerning the active substance, and that the
holder of the authorisation has, or has access to, a dossier
satisfying the requirements of Annex II to that Directive in
that
accordance with the conditions of Article 13(2) of
Directive.

By way of derogation from paragraph 1,

for each
2.
authorised plant protection product containing benthiavalicarb,
boscalid, carvone, fluoxastrobin, Paecilomyces lilacinus or prothio-
conazole as either the only active substance or as one of several
active substances all of which were listed in Annex I
to
Directive 91/414/EEC by 31 July 2008 at the latest, Member
in accordance with the
States shall re-evaluate the product
to Directive
uniform principles provided for
91/414/EEC, on the basis of
the
requirements of Annex III to that Directive and taking into
to that Directive
account part B of
the entry in Annex I
concerning benthiavalicarb, boscalid, carvone,
fluoxastrobin,
Paecilomyces lilacinus or prothioconazole. On the basis of that
evaluation, they shall determine whether the product satisfies
(d) and (e) of
the conditions set out in Article 4(1)(b),
Directive 91/414/EEC.

in Annex VI
a dossier

satisfying

(c),

(a)

in the case of a product containing benthiavalicarb, boscalid,
fluoxastrobin, Paecilomyces lilacinus or prothioco-
carvone,
the only active substance, where necessary,
nazole as
amend or withdraw the authorisation by 31 January 2010
at the latest; or

several
amend or withdraw the

(b) in the case of a product containing benthiavalicarb, boscalid,
fluoxastrobin, Paecilomyces lilacinus or prothioco-
carvone,
nazole
substances, where
active
as one of
necessary,
authorisation by
31 January 2010 or by the date fixed for
such an
in the respective Directive or
amendment or withdrawal
Directives which added the relevant substance or substances
to Annex I to Directive 91/414/EEC, whichever is the latest.

Article 4

This Directive shall enter into force on 1 August 2008.

Article 5

This Directive is addressed to the Member States.

Done at Brussels, 4 April 2008.

For the Commission

Androulla VASSILIOU
Member of the Commission

L 94/16

EN

Official Journal of the European Union

5.4.2008

x
e
n
n
A

f
o

s
e
l
p
i
c
n
i
r
p
m
r
o
f
i
n
u

e
h
t

f
o

n
o
i
t
a
t
n
e
m
e
l
p
m

i

e
h
t

r
o
F

,

b
r
a
c
i
l
a
v
a
i
h
t
n
e
b

n
o

t
r
o
p
e
r

w
e
i
v
e
r

e
h
t

f
o

s
n
o
i
s
u
l
c
n
o
c

e
h
t

,
I

V

n

i

d
e
s
i
l
a
n
i
f

s
a

,
f
o
e
r
e
h
t

I
I

d
n
a

I

s
e
c
i
d
n
e
p
p
A

r
a
l
u
c
i
t
r
a
p

n

i

d
n
a

l
a
m
n
A

i

d
n
a

n
i
a
h
C

d
o
o
F

e
h
t

n
o

e
e
t
t
i

m
m
o
C

i

g
n
d
n
a
t
S

e
h
t

.
t
n
u
o
c
c
a

o
t
n

i

n
e
k
a
t

e
b

l
l
a
h
s

8
0
0
2

y
r
a
u
n
a
J

2
2

n
o

h
t
l
a
e
H

y
a
p

t
s
u
m

s
e
t
a
t
S

r
e
b
m
e
M

t
n
e
m

s
s
e
s
s
a

l
l
a
r
e
v
o

s
i
h
t

n
I

:

o
t

n
o
i
t
n
e
t
t
a

r
a
l
u
c
i
t
r
a
p

.
s
d
o
p
o
r
h
t
r
a

t
e
g
r
a
t
-
n
o
n

f
o

n
o
i
t
c
e
t
o
r
p

e
h
t

,

y
t
e
f
a
s

r
o
t
a
r
e
p
o

e
h
t

—

—

n
o
i
t
a
g
i
t
i

m

k
s
i
r

e
t
a
u
q
e
d
a

e
d
u
l
c
n

i

l
l
a
h
s

e
s
u

f
o

s
n
o
i
t
i
d
n
o
C

.
e
t
a
i
r
p
o
r
p
p
a

e
r
e
h
w

,
s
e
r
u
s
a
e
m

n
o
i
t
c
e
t
o
r
p

t
n
a
l
p

e
s
i
r
o
h
t
u
a

o
t

s
n
o
i
t
a
c
i
l

p
p
a

g
n
i
s
s
e
s
s
a

n
I

n

i

o
t

n
a
h
t

r
e
h
t
o

s
e
s
u

r
o
f

b
r
a
c
i
l
a
v
a
i
h
t
n
e
b

i

g
n
n
i
a
t
n
o
c

s
t
c
u
d
o
r
p

n
o
i
t
n
e
t
t
a

r
a
l
u
c
i
t
r
a
p

y
a
p

l
l
a
h
s

s
e
t
a
t
S

r
e
b
m
e
M

,
s
e
s
u
o
h
s
s
a
l
g

B

t
r
a
P

.

d
e
s
i
r
o
h
t
u
a

e
b

y
a
m

e
d
i
c
i
g
n
u
f

s
a

s
e
s
u

y
l
n
O

y
n
a

t
a
h
t

e
r
u
s
n
e

l
l
a
h
s

d
n
a

,
)
b
(
)

1
4

(

e
l
c
i
t
r
A

n

i

a
i
r
e
t
i
r
c

e
h
t

n
a

h
c
u
s

e
r
o
f
e
b

d
e
d
i
v
o
r
p

s
i

n
o
i
t
a
m
r
o
f
n

i

d
n
a

a
t
a
d

y
r
a
s
s
e
c
e
n

.

d
e
t
n
a
r
g

s
i

n
o
i
t
a
s
i
r
o
h
t
u
a

n

i

n
o
i
s
s
i

m
m
o
C

e
h
t

m
r
o
f
n

i

l
l
a
h
s

s
e
t
a
t
S

r
e
b
m
e
M

e
h
T

e
h
t

f
o

n
o
i
t
a
c
i
f
i
c
e
p
s

e
h
t

n
o

)

(

5
3
1

e
l
c
i
t
r
A

h
t
i

w

e
c
n
a
d
r
o
c
c
a

.

d
e
r
u
t
c
a
f
u
n
a
m

y
l
l
a
i
c
r
e
m
m
o
c

s
a

l
a
i
r
e
t
a
m

l
a
c
i
n
h
c
e
t

:
e
l
o
z
a
i
h
t
o
z
n
e
b
d
-

i

,

′
2
2
-
o
r
o
u
l
f
i
d
-

′
6
6

,

)
l
y
n
e
h
p
o
r
o
u
l
f
-
5
-
o
n
m
a
-
2
(
s
i
b

i

g
k
/
g
m

4
1
<

:
e
d
i
f
l
u
s
i
d

g
k
/
g
m

,

5
3
<

-
u
p
m

i

g
n
i
r
u
t
c
a
f
u
n
a
m
g
n
w
o

i

l
l

o
f

e
h
T

n
r
e
c
n
o
c

l

l
a
c
i
g
o
o
c
i
x
o
t

f
o

e
r
a

s
e
i
t
i
r

d
e
e
c
x
e

t
o
n

t
s
u
m

m
e
h
t

f
o

h
c
a
e

d
n
a

l
a
c
i
n
h
c
e
t

e
h
t

n

i

t
n
u
o
m
a

n
i
a
t
r
e
c

a

:
l
a
i
r
e
t
a
m

]
l
y
p
o
r
p
l
y
h
t
e
m
-
2
-
}
l
y
o
m
a
b
r
a
c
]
l
y
h
t
e

)
l
y
-
2
-
l
o
z
a
i
h
t
o
z
n
e
b

d
i
c
a

c
i
m
a
b
r
a
c

7
-
5
3
-
5
1
6
3
1
4

o
N

S
A
C

4
4
7

o
N

C
A
P
I
C

A

t
r
a
P

8
1
0
2

y
l
u
J

1
3

8
0
0
2

t
s
u
g
u
A

1

g
k
/
g

0
1
9
≥

,

-
3
1
-
o
r
o
u
l
f
-
6
(
-
1
-
)
R
(
[
{
-
1
-
)
S
(
[

b
r
a
c
i
l
a
v
a
i
h
t
n
e
B

9
6
1

‘

s
n
o
i
s
i
v
o
r
p

c
i
f
i
c
e
p
S

f
o

n
o
i
t
a
r
i
p
x
E

n
o
i
s
u
l
c
n

i

e
c
r
o
f

o
t
n

i

y
r
t
n
E

)
*
(

y
t
i
r
u
P

e
m
a
n

C
A
P
U

I

X
E
N
N
A

:
e
l
b
a
t

e
h
t

f
o

d
n
e

e
h
t

t
a

d
e
d
d
a

e
r
a

s
w
o
r

i

g
n
w
o

l
l

o
f

e
h
t

,

C
E
E
/
4
1
4
/
1
9

e
v
i
t
c
e
r
i

D

o
t

I

x
e
n
n
A

n
I

,
e
m
a
n

n
o
m
m
o
C

s
r
e
b
m
u
n

n
o
i
t
a
c
i
f
i
t
n
e
d

i

o
N

5.4.2008

EN

Official Journal of the European Union

L 94/17

x
e
n
n
A

f
o

s
e
l
p
i
c
n
i
r
p
m
r
o
f
i
n
u

e
h
t

f
o

n
o
i
t
a
t
n
e
m
e
l
p
m

i

e
h
t

r
o
F

n

i

d
n
a

,

d

i
l
a
c
s
o
b

n
o

t
r
o
p
e
r

w
e
i
v
e
r

e
h
t

f
o

s
n
o
i
s
u
l
c
n
o
c

e
h
t

,
I

V

e
h
t

n

i

d
e
s
i
l
a
n
i
f

s
a

,
f
o
e
r
e
h
t

I
I

d
n
a

I

s
e
c
i
d
n
e
p
p
A

r
a
l
u
c
i
t
r
a
p

h
t
l
a
e
H

l
a
m
n
A

i

d
n
a

n
i
a
h
C

d
o
o
F

e
h
t

n
o

e
e
t
t
i

m
m
o
C

i

g
n
d
n
a
t
S

.
t
n
u
o
c
c
a

o
t
n

i

n
e
k
a
t

e
b

l
l
a
h
s

8
0
0
2

y
r
a
u
n
a
J

2
2

n
o

y
a
p

t
s
u
m

s
e
t
a
t
S

r
e
b
m
e
M

t
n
e
m

s
s
e
s
s
a

l
l
a
r
e
v
o

s
i
h
t

n
I

n
o
i
t
n
e
t
t
a

r
a
l
u
c
i
t
r
a
p

s
i

e
c
n
a
t
s
b
u
s

e
h
t

f
i

l
i

o
s

n

i

n
o
i
t
a
l
u
m
u
c
c
a

f
o

k
s
i
r

e
h
t

o
t

p
o
r
c

n

i

s
p
o
r
c

i

g
n
d
e
e
c
c
u
s

n

i

r
o

s
p
o
r
c

l
a
i
n
n
e
r
e
p

n

i

d
e
s
u

,
s

m

s
i
n
a
g
r
o

l
i

o
s

d
n
a

s
d
r
i
b

o
t

k
s
i
r

m
r
e
t

g
n
o

l

e
h
t

o
t

.

n
o
i
t
a
t
o
r

,

y
t
e
f
a
s

r
o
t
a
r
e
p
o

e
h
t

o
t

—

—

—

n
o
i
t
a
g
i
t
i

m

k
s
i
r

e
t
a
u
q
e
d
a

e
d
u
l
c
n

i

l
l
a
h
s

e
s
u

f
o

s
n
o
i
t
i
d
n
o
C

.
e
t
a
i
r
p
o
r
p
p
a

e
r
e
h
w

,
s
e
r
u
s
a
e
m

B

t
r
a
P

.

d
e
s
i
r
o
h
t
u
a

e
b

y
a
m

e
d
i
c
i
g
n
u
f

s
a

s
e
s
u

y
l
n
O

A

t
r
a
P

8
1
0
2

y
l
u
J

1
3

8
0
0
2

t
s
u
g
u
A

1

g
k
/
g

0
6
9
≥

-
2
-
l
y
n
e
h
p
b
o
r
o
h
c
-

l

i

′
4
(
-

N
-
o
r
o
h
C
-
2

l

d

i
l
a
c
s
o
B

0
7
1

i

e
d
m
a
n
i
t
o
c
i
n
)
l
y

6
-
5
8
-
5
2
4
8
8
1

o
N

S
A
C

3
7
6

o
N

C
A
P
I
C

s
n
o
i
s
i
v
o
r
p

c
i
f
i
c
e
p
S

f
o

n
o
i
t
a
r
i
p
x
E

n
o
i
s
u
l
c
n

i

e
c
r
o
f

o
t
n

i

y
r
t
n
E

)
*
(

y
t
i
r
u
P

e
m
a
n

C
A
P
U

I

,
e
m
a
n

n
o
m
m
o
C

s
r
e
b
m
u
n

n
o
i
t
a
c
i
f
i
t
n
e
d

i

o
N

.

d
e
s
i
r
o
h
t
u
a

e
b

y
a
m

r
o
t
a
l
u
g
e
r

h
t
w
o
r
g

t
n
a
l
p

s
a

s
e
s
u

y
l
n
O

x
e
n
n
A

f
o

s
e
l
p
i
c
n
i
r
p
m
r
o
f
i
n
u

e
h
t

f
o

n
o
i
t
a
t
n
e
m
e
l
p
m

i

e
h
t

r
o
F

n

i

d
n
a

,
e
n
o
v
r
a
c

n
o

t
r
o
p
e
r

w
e
i
v
e
r

e
h
t

f
o

s
n
o
i
s
u
l
c
n
o
c

e
h
t

,
I

V

e
h
t

n

i

d
e
s
i
l
a
n
i
f

s
a

,
f
o
e
r
e
h
t

I
I

d
n
a

I

s
e
c
i
d
n
e
p
p
A

r
a
l
u
c
i
t
r
a
p

h
t
l
a
e
H

l
a
m
n
A

i

d
n
a

n
i
a
h
C

d
o
o
F

e
h
t

n
o

e
e
t
t
i

m
m
o
C

i

g
n
d
n
a
t
S

.
t
n
u
o
c
c
a

o
t
n

i

n
e
k
a
t

e
b

l
l
a
h
s

8
0
0
2

y
r
a
u
n
a
J

2
2

n
o

y
a
p

t
s
u
m

s
e
t
a
t
S

r
e
b
m
e
M

t
n
e
m

s
s
e
s
s
a

l
l
a
r
e
v
o

s
i
h
t

n
I

.

y
t
e
f
a
s

r
o
t
a
r
e
p
o

e
h
t

o
t

n
o
i
t
n
e
t
t
a

r
a
l
u
c
i
t
r
a
p

,
s
e
r
u
s
a
e
m

n
o
i
t
a
g
i
t
i

m

k
s
i
r

e
d
u
l
c
n

i

l
l
a
h
s

e
s
u

f
o

s
n
o
i
t
i
d
n
o
C

.
e
t
a
i
r
p
o
r
p
p
a

e
r
e
h
w

B

t
r
a
P

:

1
0
0
1

t
s
a
e
l

e
n
o
-
1
-
n
e
-
2

0
-
9
4
-
9
9

o
N

S
A
C

)
e
r
u
t
x
i
m

l
/
d
(

2
0
6

o
N

C
A
P
I
C

A

t
r
a
P

8
1
0
2

y
l
u
J

1
3

8
0
0
2

t
s
u
g
u
A

1

t
a

f
o

o
i
t
a
r

l
/
d

a

h
t
i

w

g
k
/
g

0
3
9
≥

-
x
e
h
o
l
c
y
c
l
y
h
t
e
m
-
2
-
l
y
n
e
p
o
r
p
o
s
i
-
5

e
n
o
v
r
a
C

1
7
1

L 94/18

EN

Official Journal of the European Union

5.4.2008

e
h
t

g
n

i
l

d
n
a
h

n
e
h
w

r
a
l
u
c
i
t
r
a
p

n

i

,

y
t
e
f
a
s

r
o
t
a
r
e
p
o

e
h
t

e
d
u
l
c
n

i

l
l
a
h
s

e
s
u

f
o

s
n
o
i
t
i
d
n
o
C

.
e
t
a
r
t
n
e
c
n
o
c

d
e
t
u

l
i

d
n
u

e
c
a
f

a

g
n
i
r
a
e
w

s
a

h
c
u
s

,
s
e
r
u
s
a
e
m

e
v
i
t
c
e
t
o
r
p

e
t
a
u
q
e
d
a

,

d
l
e
i
h
s

n
o
i
t
a
g
i
t
i

m

k
s
i
R

.
s

m

s
i
n
a
g
r
o

c
i
t
a
u
q
a

f
o

n
o
i
t
c
e
t
o
r
p

e
h
t

e
r
e
h
w

,

d
e
i
l

p
p
a

e
b

l
l
a
h
s

s
e
n
o
z

r
e
f
f
u
b

s
a

h
c
u
s

s
e
r
u
s
a
e
m

,
e
t
a
i
r
p
o
r
p
p
a

,

i

n
b
o
r
t
s
a
x
o
u
l
f

f
o

s
e
t
i
l

o
b
a
t
e
m
e
h
t

f
o

s
e
u
d
i
s
e
r

f
o

s
l
e
v
e
l

e
h
t

i

g
n
d
e
e
f

l
a
m
n
a

i

s
a

d
e
s
u

s
i

s
a
e
r
a

d
e
t
a
e
r
t

m
o
r
f

w
a
r
t
s

n
e
h
w

r
o
f

s
n
o
i
t
c
i
r
t
s
e
r

e
d
u
l
c
n

i

l
l
a
h
s

e
s
u

f
o

s
n
o
i
t
i
d
n
o
C

.
f
f
u
t
s

,
e
t
a
i
r
p
o
r
p
p
a

e
r
e
h
w

,
s
l
a
m
n
a

i

o
t

i

g
n
d
e
e
f

e
h
t

f
i

,
e
c
a
f
r
u
s

l
i

o
s

e
h
t

n

i

n
o
i
t
a
l
u
m
u
c
c
a

f
o

k
s
i
r

e
h
t

i

g
n
d
e
e
c
c
u
s

n

i

r
o

s
p
o
r
c

l
a
i
n
n
e
r
e
p

n

i

d
e
s
u

s
i

e
c
n
a
t
s
b
u
s

.

n
o
i
t
a
t
o
r

p
o
r
c

n

i

s
p
o
r
c

—

—

—

—

,
s
e
r
u
s
a
e
m

n
o
i
t
a
g
i
t
i

m

k
s
i
r

e
d
u
l
c
n

i

l
l
a
h
s

e
s
u

f
o

s
n
o
i
t
i
d
n
o
C

.
e
t
a
i
r
p
o
r
p
p
a

e
r
e
h
w

n
o
i
s
s
i

m
b
u
s

e
h
t

t
s
e
u
q
e
r

l
l
a
h
s

s
e
t
a
t
S

r
e
b
m
e
M

d
e
n
r
e
c
n
o
c

e
h
T

t
n
e
m

s
s
e
s
s
a

k
s
i
r

c
i
t
a
u
q
a

e
v
i
s
n
e
h
e
r
p
m
o
c

a

w
o

l
l
a

o
t

a
t
a
d

,
f
f
o
-
n
u
r

,
t
f
i
r
d

y
a
r
p
s

t
n
u
o
c
c
a

o
t
n

i

i

g
n
k
a
t

e
d
a
m

e
b

o
t

-
i
t
i

m

k
s
i
r

l
a
i
t
n
e
t
o
p

f
o

s
s
e
n
e
v
i
t
c
e
f
f
e

e
h
t

d
n
a

e
g
a
n
i
a
r
d

,
s
e
r
u
s
a
e
m

n
o
i
t
a
g

m
o
r
f

w
a
r
t
s

f
i

s
e
t
i
l

o
b
a
t
e
m

t
a
r
-
n
o
n

f
o

y
t
i
c
i
x
o
t

n
o

a
t
a
d

.
f
f
u
t
s
d
e
e
f

s
a

d
e
s
u

e
b

o
t

s
i

s
a
e
r
a

d
e
t
a
e
r
t

: —
f
o

—

-
o
u
l
f

h
c
u
s

t
s
e
u
q
e
r

e
s
o
h
w

t
a

r
e
i
f
i
t
o
n

e
h
t

t
a
h
t

e
r
u
s
n
e

l
l
a
h
s

y
e
h
T

e
d
i
v
o
r
p

x
e
n
n
A

s
i
h
t

n

i

d
e
d
u
l
c
n

i

n
e
e
b

s
a
h

i

n
b
o
r
t
s
a
x

e
h
t

m
o
r
f

s
r
a
e
y

o
w

t

i

n
h
t
i

w

n
o
i
s
s
i

m
m
o
C

e
h
t

o
t

s
e
i
d
u
t
s

.

n
o
i
s
u
l
c
n

i

f
o

e
v
i
t
c
e
r
i

D

e
h
t

f
o

e
c
r
o
f

o
t
n

i

y
r
t
n
e

,

i

n
b
o
r
t
s
a
x
o
u
l
f

n
o

t
r
o
p
e
r

w
e
i
v
e
r

e
h
t

f
o

s
n
o
i
s
u
l
c
n
o
c

e
h
t

,
I

V

n

i

d
e
s
i
l
a
n
i
f

s
a

,
f
o
e
r
e
h
t

I
I

d
n
a

I

s
e
c
i
d
n
e
p
p
A

r
a
l
u
c
i
t
r
a
p

n

i

d
n
a

l
a
m
n
A

i

d
n
a

n
i
a
h
C

d
o
o
F

e
h
t

n
o

e
e
t
t
i

m
m
o
C

i

g
n
d
n
a
t
S

e
h
t

.
t
n
u
o
c
c
a

o
t
n

i

n
e
k
a
t

e
b

l
l
a
h
s

8
0
0
2

y
r
a
u
n
a
J

2
2

n
o

h
t
l
a
e
H

y
a
p

t
s
u
m

s
e
t
a
t
S

r
e
b
m
e
M

t
n
e
m

s
s
e
s
s
a

l
l
a
r
e
v
o

s
i
h
t

n
I

:

o
t

n
o
i
t
n
e
t
t
a

r
a
l
u
c
i
t
r
a
p

x
e
n
n
A

f
o

s
e
l
p
i
c
n
i
r
p
m
r
o
f
i
n
u

e
h
t

f
o

n
o
i
t
a
t
n
e
m
e
l
p
m

i

e
h
t

r
o
F

B

t
r
a
P

.

d
e
s
i
r
o
h
t
u
a

e
b

y
a
m

e
d
i
c
i
g
n
u
f

s
a

s
e
s
u

y
l
n
O

A

t
r
a
P

8
1
0
2

y
l
u
J

1
3

8
0
0
2

t
s
u
g
u
A

1

g
k
/
g

0
4
9
≥

s
n
o
i
s
i
v
o
r
p

c
i
f
i
c
e
p
S

f
o

n
o
i
t
a
r
i
p
x
E

n
o
i
s
u
l
c
n

i

e
c
r
o
f

o
t
n

i

y
r
t
n
E

)
*
(

y
t
i
r
u
P

e
m
a
n

C
A
P
U

I

-
5
-
)
y
x
o
n
e
h
p
o
r
o
h
c
-
2
(
-
6
[
-
2
{
-
)

l

E

e
n
o
n
a
h
t
e
m

)
l
y
-
3
-
n
i
z
a
x
o
d
-
2
4
1

i

,

,

e
m
i
x
o
l
y
h
t
e
m
O

-

,

i

-
o
r
d
y
h
d
-
6
5
(
}
l
y
n
e
h
p
]
y
x
o
l
y
-
4

i

-
n
d
m

i

i
r
y
p
o
r
o
u
l
f

9
-
9
2
-
7
7
3
1
6
3

o
N

S
A
C

6
4
7

o
N

C
A
P
I
C

,
e
m
a
n

n
o
m
m
o
C

s
r
e
b
m
u
n

n
o
i
t
a
c
i
f
i
t
n
e
d

i

o
N

(

i

n
b
o
r
t
s
a
x
o
u
l
F

2
7
1

5.4.2008

EN

Official Journal of the European Union

L 94/19

s
e
c
y
m
o
l
i
c
e
a
P

x
e
n
n
A

f
o

s
e
l
p
i
c
n
i
r
p
m
r
o
f
i
n
u

n
o

t
r
o
p
e
r

w
e
i
v
e
r

e
h
t

f
o

s
n
o
i
s
u
l
c
n
o
c

s
a

,
f
o
e
r
e
h
t

I
I

d
n
a

I

s
e
c
i
d
n
e
p
p
A

r
a
l
u
c
i
t
r
a
p

n

i

d
n
a

,

e
h
t

,
I

V

s
u
n
i
c
a
l
i
l

e
h
t

f
o

n
o
i
t
a
t
n
e
m
e
l
p
m

i

e
h
t

r
o
F

B

t
r
a
P

.

d
e
s
i
r
o
h
t
u
a

e
b

y
a
m

e
d
i
c
i
t
a
m
e
n

s
a

s
e
s
u

y
l
n
O

n
i
a
r
t
s

4
7
9
1

n
o
s
m
a
S

)

0
5
5
0
3
0
/
9
8

o
N

:

L
A
G
A

(

1
5
2

3
5
7

o
N

C
A
P
I
C

)

m
o
h
T

(

f
o

s
n
o
i
t
i
d
n
o
C

.
s
n
o
i
t
a
c
i
l

p
p
a

y
a
r
p
s

n

i

y
t
e
f
a
s

r
o
t
a
r
e
p
o

,
s
e
r
u
s
a
e
m

e
v
i
t
c
e
t
o
r
p

e
t
a
u
q
e
d
a

e
d
u
l
c
n

i

l
l
a
h
s

e
h
t

e
s
u

n
o
i
t
a
g
i
t
i

m

k
s
i
R

.
s

m

s
i
n
a
g
r
o

c
i
t
a
u
q
a

f
o

n
o
i
t
c
e
t
o
r
p

e
h
t

e
r
e
h
w

,

d
e
i
l

p
p
a

e
b

l
l
a
h
s

s
e
n
o
z

r
e
f
f
u
b

s
a

h
c
u
s

s
e
r
u
s
a
e
m

,
e
t
a
i
r
p
o
r
p
p
a

-
i
t
i

m

k
s
i
R

.
s
l
a
m
m
a
m

l
l
a
m

s

d
n
a

s
d
r
i
b

f
o

n
o
i
t
c
e
t
o
r
p

e
h
t

.
e
t
a
i
r
p
o
r
p
p
a

e
r
e
h
w

,

d
e
i
l

p
p
a

e
b

l
l
a
h
s

s
e
r
u
s
a
e
m

n
o
i
t
a
g

—

—

—

d
n
a

n
i
a
h
C

d
o
o
F

e
h
t

n
o

e
e
t
t
i

m
m
o
C

i

g
n
d
n
a
t
S

e
h
t

n

i

d
e
s
i
l
a
n
i
f

o
t
n

i

n
e
k
a
t

e
b

l
l
a
h
s

8
0
0
2

y
r
a
u
n
a
J

2
2

n
o

h
t
l
a
e
H

l
a
m
n
A

i

.
t
n
u
o
c
c
a

y
a
p

t
s
u
m

s
e
t
a
t
S

r
e
b
m
e
M

t
n
e
m

s
s
e
s
s
a

l
l
a
r
e
v
o

s
i
h
t

n
I

:

o
t

n
o
i
t
n
e
t
t
a

r
a
l
u
c
i
t
r
a
p

t
e
s

e
b

o
t

d
e
e
n

o
n

s
a
w

e
r
e
h
t

h
g
u
o
h
t
l
a
(

y
t
e
f
a
s

r
o
t
a
r
e
p
o

e
h
t

l

d
u
o
h
s

s

m

s
i
n
a
g
r
o
o
r
c
i
m

,
e
l
u
r

l
a
r
e
n
e
g

a

s
a

,

L
E
O
A

n
a

,
)
s
r
e
s
i
t
i
s
n
e
s

l
a
i
t
n
e
t
o
p

s
a

d
e
r
e
d
i
s
n
o
c

.
s
d
o
p
o
r
h
t
r
a

t
e
g
r
a
t
-
n
o
n

g
n

i
l
l
e
w
d

f
a
e
l

f
o

n
o
i
t
c
e
t
o
r
p

e
h
t

—

—

,
s
e
r
u
s
a
e
m

n
o
i
t
a
g
i
t
i

m

k
s
i
r

e
d
u
l
c
n

i

l
l
a
h
s

e
s
u

f
o

s
n
o
i
t
i
d
n
o
C

.
e
t
a
i
r
p
o
r
p
p
a

e
r
e
h
w

A

t
r
a
P

8
1
0
2

y
l
u
J

1
3

8
0
0
2

t
s
u
g
u
A

1

g
k
/
g

0
7
9
≥

-
3
-
)
l
y
p
o
r
p
o
l
c
y
c
o
r
o
h
c
-
1
(
-
2
[
-
2
-
)
S
R

l

(

e
l
o
z
a
n
o
c
o
h
t
o
r
P

i

4
7
1

x
e
n
n
A

f
o

s
e
l
p
i
c
n
i
r
p
m
r
o
f
i
n
u

e
h
t

f
o

n
o
i
t
a
t
n
e
m
e
l
p
m

i

i

-
o
c
o
h
t
o
r
p

n
o

t
r
o
p
e
r

w
e
i
v
e
r

e
h
t

f
o

s
n
o
i
s
u
l
c
n
o
c

e
h
t

e
h
t

r
o
F

,
I

V

s
a

,
f
o
e
r
e
h
t

I
I

d
n
a

I

s
e
c
i
d
n
e
p
p
A

r
a
l
u
c
i
t
r
a
p

n

i

d
n
a

,
e
l
o
z
a
n

n
i
a
h
C

n
e
k
a
t

d
o
o
F

e
h
t

n
o

e
e
t
t
i

m
m
o
C

i

g
n
d
n
a
t
S

e
h
t

n

i

d
e
s
i
l
a
n
i
f

e
b

l
l
a
h
s

8
0
0
2

y
r
a
u
n
a
J

2
2

n
o

h
t
l
a
e
H

l
a
m
n
A

i

.
t
n
u
o
c
c
a

d
n
a

o
t
n

i

y
a
p

t
s
u
m

s
e
t
a
t
S

r
e
b
m
e
M

t
n
e
m

s
s
e
s
s
a

l
l
a
r
e
v
o

s
i
h
t

n
I

:

o
t

n
o
i
t
n
e
t
t
a

r
a
l
u
c
i
t
r
a
p

B

t
r
a
P

.

d
e
s
i
r
o
h
t
u
a

e
b

y
a
m

e
d
i
c
i
g
n
u
f

s
a

s
e
s
u

y
l
n
O

,

,

-
1
-
l
o
z
a
i
r
t
-
4
2
1
(
-
3
-
)
l
y
n
e
h
p
o
r
o
h
c

l

g
k
/
g
5
0
<

,

:
)
l
o
-
2
-
n
a
p
o
r
p
-
)
l
y

)

D
O
L
(

-
u
p
m

i

g
n
i
r
u
t
c
a
f
u
n
a
m
g
n
w
o

i

l
l

o
f

e
h
T

n
r
e
c
n
o
c

l

l
a
c
i
g
o
o
c
i
x
o
t

f
o

e
r
a

s
e
i
t
i
r

d
e
e
c
x
e

t
o
n

t
s
u
m

m
e
h
t

f
o

h
c
a
e

d
n
a

l
a
c
i
n
h
c
e
t

e
h
t

n

i

t
n
u
o
m
a

n
i
a
t
r
e
c

a

:
l
a
i
r
e
t
a
m

-
2
(
-
1

)
l
y
p
o
r
p
o
l
c
y
c
o
r
o
h
c
-
1
(
-
2

l

(

i

o
h
t
s
e
d
-
e
l
o
z
a
n
o
c
o
h
t
o
r
P

i

g
k
/
g
5
<

:
e
n
e
u
o
T

l

—

—

,

i

-
o
r
d
y
h
d
-
4
2
-
]
l
y
p
o
r
p
y
x
o
r
d
y
h

-
2
-
)
l
y
n
e
h
p
o
r
o
h
c
-
2

l

(

i

e
n
o
h
t
-
3
-
e
l
o
z
a
i
r
t
-
4
2
1

,

,

6
-
0
7
-
8
2
9
8
7
1

o
N

S
A
C

5
4
7

o
N

C
A
P
I
C

s
n
o
i
s
i
v
o
r
p

c
i
f
i
c
e
p
S

f
o

n
o
i
t
a
r
i
p
x
E

n
o
i
s
u
l
c
n

i

e
c
r
o
f

o
t
n

i

y
r
t
n
E

)
*
(

y
t
i
r
u
P

e
m
a
n

C
A
P
U

I

,
e
m
a
n

n
o
m
m
o
C

s
r
e
b
m
u
n

n
o
i
t
a
c
i
f
i
t
n
e
d

i

o
N

A

t
r
a
P

8
1
0
2

y
l
u
J

1
3

8
0
0
2

t
s
u
g
u
A

1

e
l
b
a
c
i
l

p
p
a

t
o
N

s
u
n
i
c
a
l
i
l

s
e
c
y
m
o
l
i
c
e
a
P

3
7
1

L 94/20

EN

Official Journal of the European Union

5.4.2008

,
s
e
r
u
s
a
e
m

n
o
i
t
a
g
i
t
i

m

k
s
i
r

e
d
u
l
c
n

i

l
l
a
h
s

e
s
u

f
o

s
n
o
i
t
i
d
n
o
C

.
e
t
a
i
r
p
o
r
p
p
a

e
r
e
h
w

n
o
i
s
s
i

m
b
u
s

e
h
t

t
s
e
u
q
e
r

l
l
a
h
s

s
e
t
a
t
S

r
e
b
m
e
M

d
e
n
r
e
c
n
o
c

e
h
T

r
e
m
u
s
n
o
c

f
o

t
n
e
m

s
s
e
s
s
a

e
h
t

w
o

l
l
a

o
t

n
o
i
t
a
m
r
o
f
n

i

y
r
a
m

i
r
p

n

i

s
e
v
i
t
a
v
i
r
e
d

e
t
i
l

o
b
a
t
e
m

e
l
o
z
a
i
r
t

o
t

e
r
u
s
o
p
x
e

,

n
i
g
i
r
o

l
a
m
n
a

i

f
o

s
t
c
u
d
o
r
p

d
n
a

,
s
p
o
r
c

l
a
n
o
i
t
a
t
o
r

,
s
p
o
r
c

e
l
o
z
a
n
o
c
o
h
t
o
r
p

i

f
o

n
o
i
t
c
a

f
o

e
d
o
m
e
h
t

f
o

n
o
s
i
r
a
p
m
o
c

a

e
h
t

e
h
t

w
o

l
l
a

o
t

s
e
v
i
t
a
v
i
r
e
d

e
t
i
l

o
b
a
t
e
m

e
l
o
z
a
i
r
t

e
h
t

d
n
a

m
o
r
f

g
n
i
t
l
u
s
e
r

y
t
i
c
i
x
o
t

e
h
t

f
o

t
n
e
m

s
s
e
s
s
a

,
s
d
n
u
o
p
m
o
c

e
s
e
h
t

o
t

e
r
u
s
o
p
x
e

i

d
e
n
b
m
o
c

o
t

k
s
i
r

m
r
e
t
-
g
n
o

l

e
h
t

s
s
e
r
d
d
a

r
e
h
t
r
u
f

o
t

n
o
i
t
a
m
r
o
f
n

i

e
s
u

e
h
t

m
o
r
f

g
n
i
s
i
r
a

s
l
a
m
m
a
m

d
n
a

s
d
r
i
b

s
u
o
r
o
v
i
n
a
r
g

.
t
n
e
m
t
a
e
r
t

d
e
e
s

a

s
a

e
l
o
z
a
n
o
c
o
h
t
o
r
p

i

f
o

: —
f
o

—

—

i

-
o
h
t
o
r
p

t
s
e
u
q
e
r

e
s
o
h
w

t
a

r
e
i
f
i
t
o
n

e
h
t

t
a
h
t

e
r
u
s
n
e

l
l
a
h
s

y
e
h
T

h
c
u
s

e
d
i
v
o
r
p

x
e
n
n
A

s
i
h
t

n

i

d
e
d
u
l
c
n

i

n
e
e
b

s
a
h

e
l
o
z
a
n
o
c

s
n
o
i
s
i
v
o
r
p

c
i
f
i
c
e
p
S

f
o

n
o
i
t
a
r
i
p
x
E

n
o
i
s
u
l
c
n

i

e
c
r
o
f

o
t
n

i

y
r
t
n
E

)
*
(

y
t
i
r
u
P

e
m
a
n

C
A
P
U

I

,
e
m
a
n

n
o
m
m
o
C

s
r
e
b
m
u
n

n
o
i
t
a
c
i
f
i
t
n
e
d

i

o
N

e
h
t

m
o
r
f

s
r
a
e
y

o
w

t

i

n
h
t
i

w

n
o
i
s
s
i

m
m
o
C

e
h
t

o
t

s
e
i
d
u
t
s

’

.

n
o
i
s
u
l
c
n

i

f
o

e
v
i
t
c
e
r
i

D

e
h
t

f
o

e
c
r
o
f

o
t
n

i

y
r
t
n
e

.
t
r
o
p
e
r

w
e
i
v
e
r

e
h
t

n

i

d
e
d
i
v
o
r
p

e
r
a

s
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

f
o

n
o
i
t
a
c
i
f
i
c
e
p
s

d
n
a

y
t
i
t
n
e
d

i

n
o

s
l
i
a
t
e
d

r
e
h
t
r
u
F

)
*
(